We actively communicate on our business, services and technical capabilities. Use the resources on this page to browse through recent news, to subscribe to our news services or to meet us at one of our forthcoming events.
Needle-to-needle’: Manufacturing NeoAntigen peptides
28 Feb 2019 - Trishul Shah of PolyPeptide Laboratories looks at the prospects for individualised peptide therapeutics* […]
Read moreConsiderations for multi-product manufacturing facilities
30 Jan 2017 - Trishul Shah, Associate Director Business Development at PolyPeptide Laboratories Inc, reviews the considerations for the manufacture of active pharmaceutical ingredients at a multi-product facility.[…]
Read moreDesigning quality into therapeutic peptide manufacturing
1 Dec 2014 - The PolyPeptide Group has embraced quality by design and uses a risk based approach to develop, manufacture and commercialize peptide based therapeutics.[…]
Read moreProcess validation: Manufacturing peptide APIs
28 May 2014 - Trishul Shah of the Polypeptide Group overviews the steps involved in the life-cycle approach encouraged by the US FDA in API manufacture.[…]
Read moreBioconjugates: The adaptable challenge
2013 - Trishul Shah, BioPharm International, January 2013 Read more
Read more